Joint Formulary & PAD

Acamprosate calcium - Alcohol dependence

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Tablets
Associated Icons :
SPC
Restrictions / Comments :

PAD Profile

ChemicalSubstance :
Acamprosate calcium
Indication :
Alcohol dependence
Group Name :
Keywords :
alcohol abstinence, abstinence from alcohol, alcohol dependency, alcohol abuse
Brand Names Include :
Campral EC
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1

Committee Recommendations (1)

The Surrey Heartlands integrated care system Area Prescribing Committee (APC) agreed the use of naltrexone and acamprosate for reducing alcohol consumption in people with alcohol dependence.

Naltrexone and acamprosate will be given a RED traffic light status, for prescribing by Drug and Alcohol teams only.

Any prescribing established in primary care prior to this decision may continue.

Other Indications

Below are listed other indications that Acamprosate calcium is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Alcohol dependence.